Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Molecular Diagnostics dealmaking
2.1. Introduction
2.2. Molecular Diagnostics partnering over the years
2.3. Most active Molecular Diagnostics dealmakers
2.4. Molecular Diagnostics partnering by deal type
2.5. Molecular Diagnostics partnering by therapy area
2.6. Deal terms for Molecular Diagnostics partnering
2.6.1 Molecular Diagnostics partnering headline values
2.6.2 Molecular Diagnostics deal upfront payments
2.6.3 Molecular Diagnostics deal milestone payments
2.6.4 Molecular Diagnostics royalty rates

Chapter 3 – Leading Molecular Diagnostics deals
3.1. Introduction
3.2. Top Molecular Diagnostics deals by value

Chapter 4 – Most active Molecular Diagnostics dealmakers
4.1. Introduction
4.2. Most active Molecular Diagnostics dealmakers
4.3. Most active Molecular Diagnostics partnering company profiles

Chapter 5 – Molecular Diagnostics contracts dealmaking directory
5.1. Introduction
5.2. Molecular Diagnostics contracts dealmaking directory

Chapter 6 – Molecular Diagnostics dealmaking by technology type

Appendices
Appendix 1 – Molecular Diagnostics deals by company A-Z
Appendix 2 – Molecular Diagnostics deals by stage of development
Appendix 3 – Molecular Diagnostics deals by deal type
Appendix 4 – Molecular Diagnostics deals by therapy area
Appendix 5 – Deal type definitions
Appendix 6 – Further Reading

About Wildwood Ventures


Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Molecular Diagnostics partnering since 2015
Figure 2: Active Molecular Diagnostics dealmaking activity
Figure 3: Molecular Diagnostics partnering by deal type since 2015
Figure 4: Molecular Diagnostics partnering by disease type since 2015
Figure 5: Molecular Diagnostics deals with a headline value
Figure 6: Molecular Diagnostics deals with an upfront value
Figure 7: Molecular Diagnostics deals with a milestone value
Figure 8: Molecular Diagnostics deals with a royalty rate value
Figure 9: Top Molecular Diagnostics deals by value since 2015
Figure 10: Most active Molecular Diagnostics dealmakers 2015 to 2022